Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Neurocrine Biosciences, Inc..

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Buy	2.5M	2.5M	+13K	€98.06–€147.50
2024-Q4	Sell	2.6M	2.5M	-85K	€102.05–€133.60
2024-Q3	Buy	2.5M	2.6M	+106K	€103.20–€144.20
2024-Q2	Buy	2.3M	2.5M	+217K	€122.90–€135.95
2024-Q1	Buy	2M	2.3M	+263K	€118.15–€134.25
2023-Q4	Buy	1.6M	2M	+398K	€98.96–€119.45
2023-Q3	Sell	1.6M	1.6M	-53K	€84.56–€109.05
2023-Q2	Sell	1.9M	1.6M	-304K	€83.54–€94.98
2023-Q1	Buy	1.6M	1.9M	+333K	€87.84–€115.46
2022-Q4	Buy	1.4M	1.6M	+171K	€107.70–€128.38
2022-Q3	Sell	1.4M	1.4M	-6.6K	€89.93–€108.78
2022-Q2	Buy	1.3M	1.4M	+169K	€71.78–€94.52
2022-Q1	Sell	1.4M	1.3M	-144K	€63.62–€85.82
2021-Q4	Buy	1.4M	1.4M	+68K	€69.76–€92.06
2021-Q3	Buy	1.2M	1.4M	+113K	€72.82–€83.14
2021-Q2	Sell	1.4M	1.2M	-155K	€73.30–€84.98
2021-Q1	Sell	1.8M	1.4M	-409K	€73.80–€97.98
2020-Q4	Sell	2.1M	1.8M	-342K	€72.80–€93.54
2020-Q3	Buy	1.5M	2.1M	+665K	€81.56–€117.65
2020-Q2	Buy	719K	1.5M	+765K	€77.12–€116.50
2020-Q1	Sell	739K	719K	-20K	€67.70–€101.85
2019-Q4	Buy	3.9K	739K	+735K	€78.80–€109.00
2019-Q3	Sell	15K	3.9K	-11K	€73.56–€91.54
2019-Q2	Sell	228K	15K	-213K	€64.52–€80.49
2019-Q1	Buy	76K	228K	+152K	€60.82–€79.50
2018-Q4	Sell	162K	76K	-87K	€60.20–€107.37
2018-Q1	Sell	387K	162K	-225K	€60.50–€73.93
2017-Q4	Buy	131K	387K	+257K	€49.11–€63.98

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors